Business Wire

PQ Bypass Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease

MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass, an innovative medical device company pioneering advancements in the treatment of complex peripheral artery disease (PAD), announces enrollment of the ...
Business Wire

PQ Bypass Receives IDE Approval to Initiate Study of First-of-its-Kind Procedure for Patients Suffering From Peripheral Artery Disease

SUNNYVALE, Calif.--(BUSINESS WIRE)--PQ Bypass, Inc., today announced it has received conditional approval of its investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) ...
Healio

Endologix acquires PQ Bypass, developer of percutaneous femoral-popliteal bypass for PAD

Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...
BioWorld

DETOUR2 shows Endologix superficial femoral artery bypass on track

One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...